Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (
Animals
Autoradiography
Benzofurans
/ metabolism
Brain Neoplasms
/ diagnostic imaging
Cell Line, Tumor
Disease Models, Animal
Female
Fluorine Radioisotopes
Glioblastoma
/ diagnostic imaging
Humans
Magnetic Resonance Imaging
Mice
Mice, Knockout
Mice, Nude
Molecular Imaging
/ methods
Piperidines
/ metabolism
Positron-Emission Tomography
/ methods
Radiopharmaceuticals
Receptors, sigma
/ genetics
Transplantation, Heterologous
Sigma-1 Receptor
(S)-(−)-[18F]fluspidine
imaging-based biomarker
orthotopic xenograft of glioblastoma in mouse
sigma-1 receptor availability
small animal Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI)
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 May 2020
06 May 2020
Historique:
received:
13
04
2020
revised:
30
04
2020
accepted:
02
05
2020
entrez:
10
5
2020
pubmed:
10
5
2020
medline:
5
3
2021
Statut:
epublish
Résumé
Glioblastoma multiforme (GBM) is the most devastating primary brain tumour characterised by infiltrative growth and resistance to therapies. According to recent research, the sigma-1 receptor (sig1R), an endoplasmic reticulum chaperone protein, is involved in signaling pathways assumed to control the proliferation of cancer cells and thus could serve as candidate for molecular characterisation of GBM. To test this hypothesis, we used the clinically applied sig1R-ligand (
Identifiants
pubmed: 32384802
pii: molecules25092170
doi: 10.3390/molecules25092170
pmc: PMC7248975
pii:
doi:
Substances chimiques
1'-benzyl-3-(2-fluoroethyl)-3H-spiro((2)benzofuran-1,4'-piperidine)
0
Benzofurans
0
Fluorine Radioisotopes
0
Piperidines
0
Radiopharmaceuticals
0
Receptors, sigma
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Pathol. 2012 May;180(5):2108-19
pubmed: 22440258
EJNMMI Res. 2015 Dec;5(1):49
pubmed: 26384292
Life Sci. 2000 Apr 7;66(20):1979-86
pubmed: 10821122
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1167-75
pubmed: 19247652
Curr Med Chem. 2014;21(1):35-69
pubmed: 23992342
Nucl Med Biol. 2006 Feb;33(2):211-5
pubmed: 16546675
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1024-1026
pubmed: 32040610
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6562-70
pubmed: 26554014
Neoplasia. 2007 May;9(5):358-69
pubmed: 17534441
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2613-2617
pubmed: 30256068
Cancer Res. 2002 Jan 1;62(1):313-22
pubmed: 11782394
J Clin Neurosci. 2018 Aug;54:7-13
pubmed: 29801989
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1199-209
pubmed: 24604590
Cancer Res. 2007 Dec 1;67(23):11166-75
pubmed: 18056441
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2703-14
pubmed: 25173780
Eur J Pharmacol. 1993 Jan 15;244(2):199-201
pubmed: 8094338
Mol Pharmacol. 2013 Nov;84(5):751-62
pubmed: 24006496
Molecules. 2018 Mar 20;23(3):
pubmed: 29558382
J Nucl Med. 2006 Jan;47(1):150-4
pubmed: 16391199
J Nucl Med. 2014 Aug;55(8):1380-8
pubmed: 24914058
Cancer Res. 1991 Dec 15;51(24):6558-62
pubmed: 1660342
Front Oncol. 2019 May 17;9:417
pubmed: 31165048
Nat Rev Clin Oncol. 2019 Aug;16(8):509-520
pubmed: 30733593
Life Sci. 1990;46(18):1279-86
pubmed: 1971702
Nucl Med Biol. 2013 May;40(4):445-50
pubmed: 23528561
Cells. 2020 Feb 20;9(2):
pubmed: 32093304
Int J Inflam. 2015;2015:385030
pubmed: 26798546
Curr Neuropharmacol. 2008 Dec;6(4):344-66
pubmed: 19587856
Life Sci. 1995;56(26):2385-92
pubmed: 7791525
J Neuroinflammation. 2015 Feb 17;12:29
pubmed: 25889537
Cancer J. 2015 Mar-Apr;21(2):129-36
pubmed: 25815854
Molecules. 2020 Jan 28;25(3):
pubmed: 32012954
Eur J Neurosci. 2003 Oct;18(8):2188-96
pubmed: 14622179
Biochem Biophys Res Commun. 1996 Feb 6;219(1):219-26
pubmed: 8619811
Future Med Chem. 2018 Sep 1;10(18):2227-2236
pubmed: 30089425
J Med Chem. 2015 Jul 23;58(14):5395-407
pubmed: 26090686
J Clin Oncol. 2017 Jul 20;35(21):2450-2456
pubmed: 28640704
Cancer Lett. 2006 Oct 28;242(2):245-57
pubmed: 16388898
ACS Med Chem Lett. 2018 May 01;9(7):606-611
pubmed: 30034587
PLoS One. 2013;8(3):e59689
pubmed: 23555746
J Pain Res. 2018 Oct 12;11:2353-2357
pubmed: 30349360
Mol Pharmacol. 2016 Jan;89(1):142-53
pubmed: 26560551
Sci Rep. 2019 Dec 30;9(1):20311
pubmed: 31889117
Trends Mol Med. 2012 Jun;18(6):311-6
pubmed: 22595628
Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):106-13
pubmed: 15322732
Subcell Biochem. 2010;51:381-98
pubmed: 20213551
Biochem Pharmacol (Los Angel). 2012 Aug 8;1:
pubmed: 25346877
Neurochem Res. 1996 Nov;21(11):1309-14
pubmed: 8947921
Cell Stress Chaperones. 2015 Sep;20(5):729-41
pubmed: 26070366
Nucl Med Biol. 2007 Jul;34(5):571-7
pubmed: 17591557
Clin Nucl Med. 2017 Oct;42(10):e433-e435
pubmed: 28737579
J Nucl Med. 2013 Aug;54(8):1377-83
pubmed: 23785170
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):540-51
pubmed: 21072511
J Pharm Pharmacol. 2009 May;61(5):631-40
pubmed: 19406002
Mol Biol Cell. 1992 Jun;3(6):613-9
pubmed: 1323349
Neuropharmacology. 2018 Jun;135:328-342
pubmed: 29580951
Trends Pharmacol Sci. 2016 Apr;37(4):262-278
pubmed: 26869505
Handb Exp Pharmacol. 2017;244:237-308
pubmed: 28744586
Cancer Res. 1995 Jan 15;55(2):408-13
pubmed: 7812973
Front Physiol. 2013 Jul 16;4:175
pubmed: 23882221
Curr Pharm Des. 2010;16(31):3519-37
pubmed: 21050178
Synapse. 2006 May;59(6):350-8
pubmed: 16463398
Semin Oncol. 2011 Feb;38(1):55-69
pubmed: 21362516
Cancer Res. 2004 Jul 15;64(14):4875-86
pubmed: 15256458
Curr Protoc Pharmacol. 2015 Dec 08;71:1.34.1-1.34.21
pubmed: 26646191
J Nucl Med. 2014 Oct;55(10):1730-6
pubmed: 25071097
Int J Mol Sci. 2019 Sep 20;20(19):
pubmed: 31547109
Molecules. 2020 Mar 24;25(6):
pubmed: 32213992
Eur J Cancer. 2009 Nov;45(16):2893-905
pubmed: 19679463
Eur J Pharmacol. 1992 Dec 1;227(4):371-8
pubmed: 1359973